BOSTON — The US Food and Drug Administration (FDA) approved 55 new medications in 2023 and 11 more in 2024 to date. During a presentation on April 18 at the annual American College of Physicians Internal Medicine Meeting, Gerald Smetana, MD, professor of medicine in the Division of General Medicine at Beth Israel Deaconess Medical...
Category: <span>Clinical Practice</span>
Post
Home Phototherapy for Psoriasis: Encouraging New Data, Optimizing Access – biomed tech
Doug Brunk May 22, 2024 Supporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of Dermatology (AAD) in March. There, Joel M. Gelfand, MD, professor of dermatology and epidemiology at the University of Pennsylvania in Philadelphia, presented results from the...
Post
Psoriasis Linked to Higher Incidence of MACE Despite Statin Use
Over a period of 5 years, the likelihood of major adverse cardiovascular events (MACE) in patients with psoriasis and dyslipidemia who were on statin therapy was 40% greater than that in non-psoriasis patients with dyslipidemia on statin therapy, even after adjusting for covariates, results from a large retrospective study showed. “It is well-established that psoriasis...
Post
The bird flu outbreak has spread to humans — are we too late to prevent the next pandemic?
BY RACHAEL PILTCH-LOEB, DENIS NASH AND SCOTT RATZAN, OPINION CONTRIBUTORS – 06/08/24 9:00 AM ETWe learned on May 30 of a third human case of H5N1 infection, commonly known as bird flu, in the United States. This case was on a different farm than previous cases and presented with different symptoms. Since March 29, there...
Post
New ‘FLiRT’ COVID Variants Could Be Driving an Uptick in Cases. Here’s How to Avoid Them
COVID numbers are low, but some evidence suggests they could be rising. Here’s how to protect yourself this summer, according to experts BY LAUREN J. YOUNG Allen J. Schaben/Los Angeles Times via Getty Images Editor’s Note (6/5/25): Today the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee unanimously voted in favor of...
Post
Patients With Hypersensitivity Pneumonitis Share What Keeps Them Up at Night
Adults with hypersensitivity pneumonitis (HP) expressed interest in more knowledge of prognosis, etiology, treatment, and living well with the disease, based on new survey data presented at the American Thoracic Society International Conference. HP is caused by environmental exposure and is often incurable, and patients are challenged with identifying and mitigating the exposure with limited...
Post
Can losing your sense of smell predict heart failure?
JUNE 10, 2024 by Laura Williamson, American Heart Association Credit: Pixabay/CC0 Public DomainLosing the ability to smell properly—a common sensory deficit as people age—may help predict or even contribute to the development of heart failure, new research suggests. The study, published in the Journal of the American Heart Association, adds to a growing body of...
Post
Experts develop nutritional recommendations for patients treated with anti-obesity medications
NEWS RELEASE 10-JUN-2024 Peer-Reviewed PublicationTHE OBESITY SOCIETY ROCKVILLE, Md.— Individuals treated with anti-obesity medications generally experience reduced appetite, which typically leads to reduced food intake. As a result, dietary quality becomes more important because nutritional needs must be met within the context of eating less. To improve this process, medical experts have developed a list...
Post
When is genome sequencing advisable?
NEWS RELEASE 10-JUN-2024 When is genome sequencing advisable? Peer-Reviewed PublicationUNIVERSITÄT LEIPZIG Genetic mutations in human DNA can prevent proteins that perform important functions in the body from being formed correctly. This can lead to serious disorders that cause disease or even disability. Many of these diseases are already known and can be attributed to specific...
Post
For type 1 diabetes distress, focus first on managing emotions
NEWS RELEASE 10-JUN-2024 Peer-Reviewed PublicationUNIVERSITY OF CALIFORNIA – SAN FRANCISCO FOR IMMEDIATE RELEASE Media Contact: Jess Berthold (628) 399-0432 [email protected] Subscribe to UCSF News For Type 1 Diabetes Distress, Focus First on Managing EmotionsVirtual, emotion-centered program cuts distress in half after one year, while also improving patients’ glucose control. The most effective way to reduce the...